Kimihiko Yanagita

Diabetes Mellitus Prevents an Improvement in the Serum Albumin Level During Interferon-free Sofosbuvir-based Therapy for Chronic Hepatitis C Patients: A Multi-institutional Joint Study

H. Nomura, H. Ishibashi, Kazuhiro Takahashi, 2018, Internal medicine.

Long‐term hepatic function of patients with compensated cirrhosis following successful direct‐acting antiviral treatment for hepatitis C virus infection

H. Nomura, J. Hayashi, N. Furusyo, 2021, Journal of gastroenterology and hepatology.

Malignant transformation of hepatocellular adenoma with bone marrow metaplasia arising in glycogen storage disease type I: A case report.

Y. Maehara, Y. Oda, S. Aishima, 2016, Molecular and clinical oncology.

Efficacy and safety of telaprevir, pegylated interferon α-2b and ribavirin triple therapy in Japanese patients infected with hepatitis C virus genotype 1b.

Y. Eguchi, T. Kumagai, T. Otsuka, 2015, Internal medicine.

Efficacy and Safety of Telaprevir , Pegylated Interferon α2 b and Ribavirin Triple Therapy in Japanese Patients Infected with Hepatitis C Virus Genotype 1 b

Y. Eguchi, T. Kumagai, T. Otsuka, 2015 .

Long‐term assessment of recurrence of hepatocellular carcinoma in patients with chronic hepatitis C after viral cure by direct‐acting antivirals

H. Nomura, J. Hayashi, N. Furusyo, 2021, Journal of gastroenterology and hepatology.

Development of Hepatocellular Carcinoma in Patients Aged 75–84 Years With Chronic Hepatitis C Treated With Direct-Acting Antivirals

H. Nomura, J. Hayashi, N. Furusyo, 2020, The Journal of infectious diseases.

Skin toxicities and survival in advanced hepatocellular carcinoma patients treated with sorafenib

Y. Eguchi, K. Kitahara, T. Otsuka, 2012, Hepatology research : the official journal of the Japan Society of Hepatology.

Incidence of Hepatocellular Carcinoma after Treatment with Sofosbuvir-Based or Sofosbuvir-Free Regimens in Patients with Chronic Hepatitis C

H. Nomura, J. Hayashi, N. Furusyo, 2020, Cancers.

Factors Associated with Post-Progression Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib

Y. Eguchi, T. Otsuka, S. Kawazoe, 2015, Diseases.